Find a Clinical Trial
Filter
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Non-small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Division of Thoracic Surgery
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Lung CA Dental
Non-small cell lung cancer
All genders
45+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center